info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
United States Flag  US: +1-315-636-4233    United Kingdom Flag  UK: +44-162-237-0614    Indian Flag  IN: +91-826-083-6500
smrlogonew
  • Home
  • About
    • Why SMR
    • Research Methodology
    • Media Coverage
    • Join Our Team
  • Reports
    • Aerospace and Defense
    • Agriculture
    • Automotive
    • Chemicals and Materials
    • Consumer Goods
    • Energy and Power
    • Equipment and Machinery
    • Food and Beverages
    • Healthcare
    • Information and Communication Technology
    • Semiconductor and Electronics
    • Manufacturing and Construction
  • Our Practices
    • Syndicated Research
    • Consulting Services
    • Custom Research
    • Full-time Engagement Model
  • Insights
    • Press Release
    • Blog
  • Contact
Home » Press Releases » Global Positron Emission Tomology Market worth $1508.57 million by 2030

Global Positron Emission Tomology Market worth $1508.57 million by 2030


Published Date: Apr-2022 | Report Format:Electronic (PDF)

The report ‘Global Positron Emission Tomology Market by product type (full ring and partial ring PET scanners), application (oncology, neurology, cardiology and other departments), detector type (bismuth germanium oxide, lutetium Oxyorthosilicate, gadolinium Oxyorthosilicate, lutetium fine silicate and lutetium yttrium orthosilicate), end-user (hospitals, diagnostic centres, PET centres and research institutes), and region (North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa) – Global Forecast to 2030’. In 2020, positron emission tomography had its market share valued at USD 1016.20 million globally. In 2030, the market is expected to be valued at USD 1508.57 million, with a 4.03% CAGR growth.

 

To know more about the report, Click on the link :- https://www.strategicmarketresearch.com/market-report/positron-emission-tomography-market

 

Key Factors Augmenting the Market Growth

Some of the necessary factors that assist in driving the overall growth of the market globally are the increase in the number of cancer patients and the expanded coverage of PET imaging.
 

The full-ring PET scanner market segment had the largest market share and is predicted to increase at a 5.1% CAGR by product category.

The positive emission tomology industry has been divided into full-ring PET scanners and partial-ring PET scanners based on product. The full-ring PET scanner market segment had the largest market share and is predicted to increase at a 5.1% CAGR. However, because there are no gaps in a partial-ring PET scanner, scanning patients while resting on the proton treatment bed is not practical, which leads to medical institutions preferring the full-ring PET scanner.

 

By application, the oncology segment accounted for more than 80% of the market in 2019.

The positive emission tomology industry has been divided into oncology, cardiology, neurology, and other segments based on where it is used. The oncology segment accounted for more than 80% of the market in 2019. Due to the rising need for early cancer detection and treatment, PET scanners have increased, resulting in market growth.
 

In 2016, the Lutetium Oxyorthosilicate (LSO) detector type segment had the largest market share, accounting for 36.0% of the worldwide Positron Emission Tomography (PET) scanners market.

The positive emission tomology industry has been divided into bismuth germanium oxide (BGO), lutetium Oxyorthosilicate (LSO), gadolinium Oxyorthosilicate (GSO), lutetium fine silicate (LFS) and lutetium yttrium orthosilicate (LYSO) based on where it is used. The Lutetium Oxyorthosilicate (LSO) detector type segment accounted for 36.0% of the worldwide Positron Emission Tomography (PET) scanners market. LSO crystals offer excellent light output and density, a short decay period, and excellent energy resolution, making them ideal for PET. As a result, the widespread usage of LSO has resulted in significant market growth for PET devices.


The Hospital end-user category is the largest market segment based on end-user, valued at US$ 322.7 Mn in 2015.

The PET scanners market is divided into hospitals, diagnostic centres, PET centres and research institutes based on end-users. The Hospital end-user category was valued at US$ 322.7 million in 2015. As a result of the rising need for early cancer detection and treatment and the availability of skilled medical professionals in PET, the use of PET scanners has increased, resulting in market growth.


North America held the highest market share by region, accounting for 42.2% of the global PET scanners market in 2016

The global PET market is segmented geographically into North American, European, Asia-Pacific, Latin American, and the Middle East and African regions. North America dominates the positron emission tomography industry because of the region’s high need for precise diagnoses and technological advances in PET technology.

 

Key Players Existing in the Market

The leading organisations plying in the positron emission tomology market are Agfa Healthcare, Gamma Medica Inc., GE Healthcare, Neusoft Medical Systems, Oncovision, Koninklijke Philips N.V., Positron Corporation, Siemens AG, Segami Corporation, Spectrum Dynamics Ltd., Naviscan, Inc., MedX Holdings Inc., Modus Medical Devices Inc., Radiology Oncology Systems, Inc., Yangzhou Kindsway Biotech Co. Ltd., Toshiba Corporation and Hitachi, Ltd.

 

Recent Developments

  • In January 2022, GE Healthcare received an additional FDA 510 (k) clearance for its SIGNA PET/MRI technology that could help more clinicians achieve enhanced scan efficiency.
  • In January 2022, Clario and XingImaging expanded their partnership to deliver more PET imaging clinical trials to test novel therapeutics in China.
  • In July 2021, Quibim collaborated with Full Body Insight and Oncovision with the support of GE Healthcare to build a total-body PET-CT for simultaneous whole-body imaging.
  • In June 2021, Subtle Medical received CE Mark for its SubtlePET 2.0 to expand its PET imaging capabilities.
  • In March 2021, Siemens Healthineers announced FDA Clearance on its Biograph Vision PET-CT Scanner, designed for translational and clinical use to apply scientific research to create therapies and procedures that improve health outcomes.

Choose License Type



$0
$0
$0
Buy Now
"Click to avail the latest sample copy of the report"
Request Sample
"Probe before placing the order"
Pre-Order Enquiry
"Let's optimize your ROI by furnishing the best price"
Request Discount
"Want to curate the report according to your business needs:"
Ask for Customization

Trust Online

  • paypal.png
  • wiretransfers

Follow Us

  • facebook
  • twitter
  • instagram
  • linkedin

Contact Us

  • US: (+1) 315-636-4233
  • UK: (+44) 1622-370-614
  • IN: (+91) 826-083-6500
  • info@strategicmarketresearch.com
  • Strategic Market Research
    26, Broadway Suite 934, New York , 10004

Quick Link

  • Why SMR
  • Research Methodology
  • Media Coverage
  • Join Our Team
  • Press Release
  • Blog

Customer Support

  • FAQs
  • Contact
  • Terms of Use
  • Privacy Policy
  • Disclaimer Policy
  • Return Policy
Copyright © 2022 Strategic Market Research All rights reserved